In line with previous clinical trial findings, real-world data show that bevacizumab improves outcomes in patients with ...

Haywood, MD, MPH, MMM, Xavier Ochsner College of Medicine, and Toni Flowers, PhD, DHL, MBA, LCMC Health, advocate for understanding individual patient circumstances, ultimately leading to more ...

A panelist discusses how novel targeted therapies such as antibody-drug conjugates are rapidly evolving in gynecologic ...

The Trump administration has decided to further debate the federal rule passed during the Biden administration that ...

A panelist discusses how antibody-drug conjugates like mirvetuximab should be sequenced in platinum-resistant ovarian cancer, ...

Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder ...

Second of 2 parts featuring an interview with Stephen Strickland, MD, MSCI,director, Leukemia Research for Sarah Cannon ...

Data for SKYSCRAPER-01, involving the anti-TIGIT antibody tiragolumab, seem to align with recent bad news for this ...